Pharmacotherapeutic environments for substance use disorders.
Gardner
Tracie J
TJ
Kosten
Thomas R
TR
D000553:Ambulatory Care; D002047:Buprenorphine / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003692:Delayed-Action Preparations; D005194:Family Practice; D006556:Heroin Dependence / Q000188:drug therapy / Q000534:rehabilitation; D006760:Hospitalization; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009819:Office Visits; D009293:Opioid-Related Disorders / Q000188:drug therapy / Q000534:rehabilitation; D055502:Secondary Prevention; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000534:rehabilitation
D003692:Delayed-Action Preparations; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone